The third dose of a COVID-19 vaccine boosts antibody levels
Clinical studies consistently show that administering a third dose of a COVID-19 vaccine substantially increases antibody levels and enhances immune protection.
All retrieved papers provide empirical evidence showing that a third dose (booster) of various COVID-19 vaccines effectively increases antibody titers and enhances humoral immune response. There is no contradictory evidence presented in the provided papers.
Konstantina Kontopoulou, Christos T. Nakas, Georgios Papazisis. Significant Increase in Antibody Titers after the 3rd Booster Dose of the Pfizer–BioNTech mRNA COVID-19 Vaccine in Healthcare Workers in Greece. 2022. https://doi.org/10.3390/vaccines10060876
Paper 0 found that the third booster dose of the Pfizer-BioNTech vaccine significantly increased anti-S1 RBD IgG antibody titers in healthcare workers.
See more details
Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Ronit Leiba, Avi Weissman, Michal Mekel, Gila Hyams, Nethanel A. Horowitz, Vardit Gepstein, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas. Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers. 2022. https://doi.org/10.3390/vaccines10101741
Paper 1 reported that the third BNT162b2 booster dose improved immunogenicity by yielding higher antibody concentrations among tested healthcare workers.
Domenico Tripodi, Roberto Dominici, Davide Sacco, Gennaro Santorelli, Rodolfo Rivera, Sandro Acquaviva, Marino Marchisio, Paolo Brambilla, Graziana Battini, Valerio Leoni. Antibody Response after 3-Dose Booster against SARS-CoV-2 mRNA Vaccine in Kidney Transplant Recipients. 2024. https://doi.org/10.3390/vaccines12030264
Paper 2 observed a significant increase in antibody response post-booster among kidney transplant recipients.
Suvichada Assawakosri. Immunogenicity and Safety of the Third Booster Dose with Homologous or Heterologous COVID-19 Vaccine After Completing Primary Series of Inactivated Vaccine (CoronaVac) or Adenovirus Vector Vaccine (AZD1222) in Thai Adults. https://doi.org/10.58837/chula.the.2023.672
Paper 4 demonstrated that heterologous booster vaccines significantly enhance binding and neutralizing antibody levels following primary vaccination series.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt